Pietro Leone
Research Subjects
Pietro Leone has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Julie Toby Thomas
Department of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland
6 shared publications - Sukumaran Anil
Dental Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (deemed to be University), Pimpri, Pune, India
6 shared publications - Timo Sorsa
Department of Oral and Maxillofacial Diseases University of Helsinki and Helsinki University Hospital Helsinki Finland
6 shared publications - Ismo Tapani Räisänen
Department of Oral and Maxillofacial Diseases University of Helsinki and Helsinki University Hospital Helsinki Finland
5 shared publications - Pirjo Pärnänen
Department of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland
4 shared publications - Tommi Pätilä
Department of Congenital Heart Surgery and Organ Transplantation, New Children's Hospital, University of Helsinki, Helsinki, Finland
3 shared publications
Latest Publications
- 21 September 2026
- Published by Wiley in Oral Diseases
Point‐of‐Care aMMP ‐8 Testing as an Objective Trigger for Dental Referral in Diabetes Care
- 21 September 2026
- Published by Wiley in Oral Diseases
Point‐of‐Care aMMP ‐8 Testing as an Objective Trigger for Dental Referral in Diabetes Care
- Open Access
- 8 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1042
Dual-Biomarker Oral-Rinse Testing for aMMP-8 and Calprotectin: A Potential Adjunctive Tool for Risk Stratification and Interdisciplinary Referral in Periodontitis and Type 2 Diabetes
Periodontitis is a chronic, biofilm-induced inflammatory disease characterized by episodic connective tissue destruction and is epidemiologically associated with cardiometabolic conditions, notably type 2 diabetes (T2D) and cardiovascular disease (CVD). Conventional clinical signs do not reliably distinguish quiescent from actively progressing disease, which delays intervention and interdisciplinary referral. Chair-side point-of-care testing (POCT) of oral fluids offers a pragmatic, non-invasive adjunct for real-time assessment of disease activity, not only in dental but also in medical settings. This narrative review, reported in line with the Scale for the Assessment of Narrative Review Articles (SANRA), examines the clinical rationale and current evidence for oral-rinse POCT targeting active matrix metalloproteinase-8 (aMMP-8) and calprotectin. Oral-rinse aMMP-8 reflects disease-active collagenolysis and shows the more robust single-marker performance for periodontitis, whereas oral-fluid calprotectin, a neutrophil-derived S100A8/A9 protein, behaves as a predominantly local inflammatory signal and lacks validated oral-fluid reference ranges. Combining the two markers may add information beyond either alone when used in tandem as a complementary pair, but the supporting data are heterogeneous, largely exploratory, and hypothesis-generating. Dual-biomarker oral-rinse POCT is therefore best framed as a risk-stratification and referral aid rather than a stand-alone diagnostic, with combined interpretation potentially supported by AI technologies. Standardized pre-analytics, transparent threshold reporting, oral-fluid calprotectin reference values, and prospective multicenter validation are required before broad implementation.
- 8 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1042
Open AccessDual-Biomarker Oral-Rinse Testing for aMMP-8 and Calprotectin: A Potential Adjunctive Tool for Risk Stratification and Interdisciplinary Referral in Periodontitis and Type 2 Diabetes
Periodontitis is a chronic, biofilm-induced inflammatory disease characterized by episodic connective tissue destruction and is epidemiologically associated with cardiometabolic conditions, notably type 2 diabetes (T2D) and cardiovascular disease (CVD). Conventional clinical signs do not reliably distinguish quiescent from actively progressing disease, which delays intervention and interdisciplinary referral. Chair-side point-of-care testing (POCT) of oral fluids offers a pragmatic, non-invasive adjunct for real-time assessment of disease activity, not only in dental but also in medical settings. This narrative review, reported in line with the Scale for the Assessment of Narrative Review Articles (SANRA), examines the clinical rationale and current evidence for oral-rinse POCT targeting active matrix metalloproteinase-8 (aMMP-8) and calprotectin. Oral-rinse aMMP-8 reflects disease-active collagenolysis and shows the more robust single-marker performance for periodontitis, whereas oral-fluid calprotectin, a neutrophil-derived S100A8/A9 protein, behaves as a predominantly local inflammatory signal and lacks validated oral-fluid reference ranges. Combining the two markers may add information beyond either alone when used in tandem as a complementary pair, but the supporting data are heterogeneous, largely exploratory, and hypothesis-generating. Dual-biomarker oral-rinse POCT is therefore best framed as a risk-stratification and referral aid rather than a stand-alone diagnostic, with combined interpretation potentially supported by AI technologies. Standardized pre-analytics, transparent threshold reporting, oral-fluid calprotectin reference values, and prospective multicenter validation are required before broad implementation.
- Open Access
- 6 May 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (5) , 272
Gingipain-Mediated Matrix Metalloproteinase-8 and -9 Activation in Oral Rinse Samples from Patients with Cancer: A Cross-Sectional Study
Objectives: To investigate whether Porphyromonas gingivalis gingipains contribute to the activation of MMP-8 and MMP-9 in patients with cancer and to evaluate the potential of aMMP-8 chair-side test for early detection of active periodontal inflammation in cancer care. Methods: This cross-sectional study enrolled 89 of 119 initially assessed patients with cancer at Dr. Sardjito Hospital, Yogyakarta, Indonesia (2023–2024). Active MMP-8 was quantified using a chair-side test on oral rinse samples. Total MMP-8 was measured by ELISA, MMP-9 activation by gelatin zymography, and gingipain presence by Western immunoblotting. Associations with periodontal parameters (PPD, GI, OHI-S, and VPI) were analyzed using linear regression. Results: aMMP-8 chair-side test demonstrated 91% positive results in 89 patients with cancer. Western blotting revealed the co-localization of gingipains with fragmented MMP-8. aMMP-8 levels were significantly associated with MMP-9 activation (p = 0.003, R2 = 0.097), suggesting proteolytic cascade activation. Oral hygiene indices showed stronger associations (OHI-S: p = 0.003, R2 = 0.100; VPI: p = 0.014, R2 = 0.067) than deeper periodontal parameters (PPD: p = 0.094; GI: p = 0.358), suggesting early-stage inflammation detection. Conclusions: Gingipain presence may be associated with the activation of MMP-8 and MMP-9 in patients with cancer, which links bacterial virulence to amplified tissue destruction. aMMP-8 chair-side test enables rapid identification of active inflammation, facilitating timely periodontal intervention during cancer care.
- 6 May 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (5) , 272
Open AccessGingipain-Mediated Matrix Metalloproteinase-8 and -9 Activation in Oral Rinse Samples from Patients with Cancer: A Cross-Sectional Study
Objectives: To investigate whether Porphyromonas gingivalis gingipains contribute to the activation of MMP-8 and MMP-9 in patients with cancer and to evaluate the potential of aMMP-8 chair-side test for early detection of active periodontal inflammation in cancer care. Methods: This cross-sectional study enrolled 89 of 119 initially assessed patients with cancer at Dr. Sardjito Hospital, Yogyakarta, Indonesia (2023–2024). Active MMP-8 was quantified using a chair-side test on oral rinse samples. Total MMP-8 was measured by ELISA, MMP-9 activation by gelatin zymography, and gingipain presence by Western immunoblotting. Associations with periodontal parameters (PPD, GI, OHI-S, and VPI) were analyzed using linear regression. Results: aMMP-8 chair-side test demonstrated 91% positive results in 89 patients with cancer. Western blotting revealed the co-localization of gingipains with fragmented MMP-8. aMMP-8 levels were significantly associated with MMP-9 activation (p = 0.003, R2 = 0.097), suggesting proteolytic cascade activation. Oral hygiene indices showed stronger associations (OHI-S: p = 0.003, R2 = 0.100; VPI: p = 0.014, R2 = 0.067) than deeper periodontal parameters (PPD: p = 0.094; GI: p = 0.358), suggesting early-stage inflammation detection. Conclusions: Gingipain presence may be associated with the activation of MMP-8 and MMP-9 in patients with cancer, which links bacterial virulence to amplified tissue destruction. aMMP-8 chair-side test enables rapid identification of active inflammation, facilitating timely periodontal intervention during cancer care.
- Open Access
- 2 March 2026
- Vol. 2026, 9936924
Occlusal Overload and Periodontitis: Integrating Mechanisms, Clinical Evidence, and Emerging Perspectives—A Scoping Review
Occlusal trauma has long been debated as a contributing factor in periodontitis. Excessive occlusal loading acting on inflamed tissues may accelerate periodontal breakdown through inflammatory and proteolytic pathways. This scoping review synthesizes current evidence from clinical, animal, and in vitro studies on the mechanistic and clinical interplay between occlusal trauma and periodontal degradation. In accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR), PubMed, Web of Science, Scopus, Embase, and Cochrane Library were searched for studies published 2014–2025. Clinical trials, observational studies, animal models, and in‐vitro experiments evaluating occlusal loading in periodontitis were eligible. Study selection followed the PECO framework and targeted inflammatory mediators, aMMP‐8 activity, and clinical periodontal outcomes. Eighteen studies met the inclusion criteria: eight clinical, seven animal, and three in vitro. Clinical studies have reported that occlusal adjustment, when combined with periodontal therapy, yields greater reductions in probing depth (PD), bleeding on probing (BoP), and pathogenic bacterial load compared to periodontal therapy alone. Animal and in vitro studies consistently demonstrate that mechanical loading amplifies inflammatory cytokine production (e.g., interleukin [IL]‐6 and TNF‐α), activates signaling pathways (inhibitor of kappa B kinase/nuclear factor kappa [IKK/NF‐κB] and yes‐associated protein [YAP]), and suppresses osteogenic differentiation. The release of matrix metalloproteinases (MMPs), particularly MMP‐8, was a recurring feature associated with collagen degradation. Occlusal trauma functions as a modifying factor that may exacerbate periodontitis progression in susceptible individuals, though it should not be considered an initiating cause of disease. The integration of occlusal assessment, active MMP‐8 (aMMP‐8) biomarker analysis, and targeted therapies may enhance periodontal treatment outcomes. However, the modest effect sizes observed in clinical studies suggest that selective rather than routine occlusal intervention may optimize the benefit‐to‐burden ratio. Further longitudinal and interventional studies are warranted to validate these findings and establish clinical guidelines.
- 2 March 2026
- Vol. 2026, 9936924
Open AccessOcclusal Overload and Periodontitis: Integrating Mechanisms, Clinical Evidence, and Emerging Perspectives—A Scoping Review
Occlusal trauma has long been debated as a contributing factor in periodontitis. Excessive occlusal loading acting on inflamed tissues may accelerate periodontal breakdown through inflammatory and proteolytic pathways. This scoping review synthesizes current evidence from clinical, animal, and in vitro studies on the mechanistic and clinical interplay between occlusal trauma and periodontal degradation. In accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR), PubMed, Web of Science, Scopus, Embase, and Cochrane Library were searched for studies published 2014–2025. Clinical trials, observational studies, animal models, and in‐vitro experiments evaluating occlusal loading in periodontitis were eligible. Study selection followed the PECO framework and targeted inflammatory mediators, aMMP‐8 activity, and clinical periodontal outcomes. Eighteen studies met the inclusion criteria: eight clinical, seven animal, and three in vitro. Clinical studies have reported that occlusal adjustment, when combined with periodontal therapy, yields greater reductions in probing depth (PD), bleeding on probing (BoP), and pathogenic bacterial load compared to periodontal therapy alone. Animal and in vitro studies consistently demonstrate that mechanical loading amplifies inflammatory cytokine production (e.g., interleukin [IL]‐6 and TNF‐α), activates signaling pathways (inhibitor of kappa B kinase/nuclear factor kappa [IKK/NF‐κB] and yes‐associated protein [YAP]), and suppresses osteogenic differentiation. The release of matrix metalloproteinases (MMPs), particularly MMP‐8, was a recurring feature associated with collagen degradation. Occlusal trauma functions as a modifying factor that may exacerbate periodontitis progression in susceptible individuals, though it should not be considered an initiating cause of disease. The integration of occlusal assessment, active MMP‐8 (aMMP‐8) biomarker analysis, and targeted therapies may enhance periodontal treatment outcomes. However, the modest effect sizes observed in clinical studies suggest that selective rather than routine occlusal intervention may optimize the benefit‐to‐burden ratio. Further longitudinal and interventional studies are warranted to validate these findings and establish clinical guidelines.
- Top Cited PapersOpen Access
- 20 January 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (4) , 355-371
Matrix Metalloproteinases in Periodontal and Peri‐Implant Diseases: Contribution to Their Pathogenesis, Diagnosis, and Treatment
Matrix metalloproteinases (MMPs) represent a family of 23 zinc‐dependent endopeptidases central to extracellular matrix remodeling in periodontal and peri‐implant diseases. This comprehensive review examines the pathogenic mechanisms, diagnostic applications, and therapeutic targeting potential of the entire MMP family in periodontitis and peri‐implantitis. All MMP subfamilies, collagenases (MMP‐1, ‐8, ‐13), gelatinases (MMP‐2, ‐9), stromelysins (MMP‐3, ‐10, ‐11), matrilysins (MMP‐7, ‐26), membrane‐type MMPs (MT1‐6), and others, demonstrate distinct expression patterns and substrate specificities in diseased tissues. MMP‐8 and MMP‐9 emerge as primary biomarkers, showing 5–6‐fold elevations in active periodontitis compared to health, with corresponding increases in activation ratios and decreases in tissue inhibitor of metalloproteinase (TIMP) levels. Diagnostic applications reveal point‐of‐care active MMP‐8 (aMMP‐8) immunotests achieve 70%–85% sensitivity and 65%–80% specificity for periodontitis detection, though standardization challenges limit clinical implementation. Salivary and gingival crevicular fluid MMP profiling demonstrates disease‐specific signatures, with MMP‐8/TIMP‐1 ratios serving as progression indicators. Therapeutically, MMP modulation strategies include FDA‐approved subantimicrobial dose doxycycline (SDD), which achieves a 40%–60% reduction in clinical attachment loss. Novel approaches encompass selective MMP inhibitors, pro‐resolving mediators, and host‐modulation therapies, with emerging AI‐assisted personalized treatment protocols showing promise. Critically, peri‐implantitis exhibits more severe MMP dysregulation than periodontitis, with MMP: TIMP ratios reaching 50:1 versus 20:1, accelerated bone loss patterns, and distinct MT‐MMP involvement reflecting titanium surface interactions. Translation barriers include the need for biomarker standardization, the complexity of MMP redundancy, and the requirement for personalized diagnostic thresholds. Future directions emphasize integrating MMP signatures with multi‐omics approaches, developing selective inhibitors, and establishing evidence‐based clinical guidelines for MMP‐targeted precision periodontal medicine.
- 20 January 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (4) , 355-371
Top Cited PapersOpen AccessMatrix Metalloproteinases in Periodontal and Peri‐Implant Diseases: Contribution to Their Pathogenesis, Diagnosis, and Treatment
Matrix metalloproteinases (MMPs) represent a family of 23 zinc‐dependent endopeptidases central to extracellular matrix remodeling in periodontal and peri‐implant diseases. This comprehensive review examines the pathogenic mechanisms, diagnostic applications, and therapeutic targeting potential of the entire MMP family in periodontitis and peri‐implantitis. All MMP subfamilies, collagenases (MMP‐1, ‐8, ‐13), gelatinases (MMP‐2, ‐9), stromelysins (MMP‐3, ‐10, ‐11), matrilysins (MMP‐7, ‐26), membrane‐type MMPs (MT1‐6), and others, demonstrate distinct expression patterns and substrate specificities in diseased tissues. MMP‐8 and MMP‐9 emerge as primary biomarkers, showing 5–6‐fold elevations in active periodontitis compared to health, with corresponding increases in activation ratios and decreases in tissue inhibitor of metalloproteinase (TIMP) levels. Diagnostic applications reveal point‐of‐care active MMP‐8 (aMMP‐8) immunotests achieve 70%–85% sensitivity and 65%–80% specificity for periodontitis detection, though standardization challenges limit clinical implementation. Salivary and gingival crevicular fluid MMP profiling demonstrates disease‐specific signatures, with MMP‐8/TIMP‐1 ratios serving as progression indicators. Therapeutically, MMP modulation strategies include FDA‐approved subantimicrobial dose doxycycline (SDD), which achieves a 40%–60% reduction in clinical attachment loss. Novel approaches encompass selective MMP inhibitors, pro‐resolving mediators, and host‐modulation therapies, with emerging AI‐assisted personalized treatment protocols showing promise. Critically, peri‐implantitis exhibits more severe MMP dysregulation than periodontitis, with MMP: TIMP ratios reaching 50:1 versus 20:1, accelerated bone loss patterns, and distinct MT‐MMP involvement reflecting titanium surface interactions. Translation barriers include the need for biomarker standardization, the complexity of MMP redundancy, and the requirement for personalized diagnostic thresholds. Future directions emphasize integrating MMP signatures with multi‐omics approaches, developing selective inhibitors, and establishing evidence‐based clinical guidelines for MMP‐targeted precision periodontal medicine.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1) , 9936924
Occlusal Overload and Periodontitis: Integrating Mechanisms, Clinical Evidence, and Emerging Perspectives—A Scoping Review
Background: Occlusal trauma has long been debated as a contributing factor in periodontitis. Excessive occlusal loading acting on inflamed tissues may accelerate periodontal breakdown through inflammatory and proteolytic pathways. This scoping review synthesizes current evidence from clinical, animal, and in vitro studies on the mechanistic and clinical interplay between occlusal trauma and periodontal degradation. Methods: In accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR), PubMed, Web of Science, Scopus, Embase, and Cochrane Library were searched for studies published 2014–2025. Clinical trials, observational studies, animal models, and in‐vitro experiments evaluating occlusal loading in periodontitis were eligible. Study selection followed the PECO framework and targeted inflammatory mediators, aMMP‐8 activity, and clinical periodontal outcomes. Results: Eighteen studies met the inclusion criteria: eight clinical, seven animal, and three in vitro. Clinical studies have reported that occlusal adjustment, when combined with periodontal therapy, yields greater reductions in probing depth (PD), bleeding on probing (BoP), and pathogenic bacterial load compared to periodontal therapy alone. Animal and in vitro studies consistently demonstrate that mechanical loading amplifies inflammatory cytokine production (e.g., interleukin [IL]‐6 and TNF‐α), activates signaling pathways (inhibitor of kappa B kinase/nuclear factor kappa [IKK/NF‐κB] and yes‐associated protein [YAP]), and suppresses osteogenic differentiation. The release of matrix metalloproteinases (MMPs), particularly MMP‐8, was a recurring feature associated with collagen degradation. Conclusions: Occlusal trauma functions as a modifying factor that may exacerbate periodontitis progression in susceptible individuals, though it should not be considered an initiating cause of disease. The integration of occlusal assessment, active MMP‐8 (aMMP‐8) biomarker analysis, and targeted therapies may enhance periodontal treatment outcomes. However, the modest effect sizes observed in clinical studies suggest that selective rather than routine occlusal intervention may optimize the benefit‐to‐burden ratio. Further longitudinal and interventional studies are warranted to validate these findings and establish clinical guidelines.
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1) , 9936924
Open AccessOcclusal Overload and Periodontitis: Integrating Mechanisms, Clinical Evidence, and Emerging Perspectives—A Scoping Review
Background: Occlusal trauma has long been debated as a contributing factor in periodontitis. Excessive occlusal loading acting on inflamed tissues may accelerate periodontal breakdown through inflammatory and proteolytic pathways. This scoping review synthesizes current evidence from clinical, animal, and in vitro studies on the mechanistic and clinical interplay between occlusal trauma and periodontal degradation. Methods: In accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR), PubMed, Web of Science, Scopus, Embase, and Cochrane Library were searched for studies published 2014–2025. Clinical trials, observational studies, animal models, and in‐vitro experiments evaluating occlusal loading in periodontitis were eligible. Study selection followed the PECO framework and targeted inflammatory mediators, aMMP‐8 activity, and clinical periodontal outcomes. Results: Eighteen studies met the inclusion criteria: eight clinical, seven animal, and three in vitro. Clinical studies have reported that occlusal adjustment, when combined with periodontal therapy, yields greater reductions in probing depth (PD), bleeding on probing (BoP), and pathogenic bacterial load compared to periodontal therapy alone. Animal and in vitro studies consistently demonstrate that mechanical loading amplifies inflammatory cytokine production (e.g., interleukin [IL]‐6 and TNF‐α), activates signaling pathways (inhibitor of kappa B kinase/nuclear factor kappa [IKK/NF‐κB] and yes‐associated protein [YAP]), and suppresses osteogenic differentiation. The release of matrix metalloproteinases (MMPs), particularly MMP‐8, was a recurring feature associated with collagen degradation. Conclusions: Occlusal trauma functions as a modifying factor that may exacerbate periodontitis progression in susceptible individuals, though it should not be considered an initiating cause of disease. The integration of occlusal assessment, active MMP‐8 (aMMP‐8) biomarker analysis, and targeted therapies may enhance periodontal treatment outcomes. However, the modest effect sizes observed in clinical studies suggest that selective rather than routine occlusal intervention may optimize the benefit‐to‐burden ratio. Further longitudinal and interventional studies are warranted to validate these findings and establish clinical guidelines.
- Open Access
- 20 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (22) , 2932
Active Matrixmetalloproteinase-8 in Periodontal Diagnosis: A Scoping Review
Background/Objectives : Periodontitis is a chronic inflammatory disease initiated by dysbiotic biofilms and driven by host immune dysregulation, leading to connective tissue destruction and alveolar bone loss. Its early diagnosis is closely linked to the progression and outcome of the disease. Active-matrix metalloproteinase-8 (aMMP-8) is one of the key biomarkers for estimating irreversible collagenolytic degradation. aMMP-8 is among the key biomarkers for estimating irreversible collagenolytic degradation. To evaluate the role of oral fluid/salivary/mouthrinse aMMP-8 tests for early detection and treatment monitoring of periodontitis. Methods: A search was conducted in the Medline, Embase, Scopus, and Cochrane databases, restricted to articles published between January 2020 and December 2024 to capture the most recent literature. Pilot, cohort, case–control, and cross-sectional studies were included, while studies not aligning with the objectives of this review, as well as narrative reviews, editorials, and opinions were excluded. Results: A total of 276 articles were retrieved. After removing duplicates, 226 studies remained, of which 216 were retained following title, abstract, and keyword screening. From these, 26 studies were finally included in this review. aMMP-8 point-of-care tests appear to be promising tools for early diagnosis, disease severity assessment, and treatment monitoring in periodontitis, though findings remain conflicting across studies. Elevated aMMP-8 levels are associated with active periodontal pathology and tissue destruction, reflecting ongoing collagenolytic degeneration. Conclusions: aMMP-8 mouthrinse, saliva, or oral fluid tests can be used for predictive and early diagnosis as well as for treatment monitoring in patients with periodontal disease, and they function effectively as biomarkers for periodontitis.
- 20 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (22) , 2932
Open AccessActive Matrixmetalloproteinase-8 in Periodontal Diagnosis: A Scoping Review
Background/Objectives : Periodontitis is a chronic inflammatory disease initiated by dysbiotic biofilms and driven by host immune dysregulation, leading to connective tissue destruction and alveolar bone loss. Its early diagnosis is closely linked to the progression and outcome of the disease. Active-matrix metalloproteinase-8 (aMMP-8) is one of the key biomarkers for estimating irreversible collagenolytic degradation. aMMP-8 is among the key biomarkers for estimating irreversible collagenolytic degradation. To evaluate the role of oral fluid/salivary/mouthrinse aMMP-8 tests for early detection and treatment monitoring of periodontitis. Methods: A search was conducted in the Medline, Embase, Scopus, and Cochrane databases, restricted to articles published between January 2020 and December 2024 to capture the most recent literature. Pilot, cohort, case–control, and cross-sectional studies were included, while studies not aligning with the objectives of this review, as well as narrative reviews, editorials, and opinions were excluded. Results: A total of 276 articles were retrieved. After removing duplicates, 226 studies remained, of which 216 were retained following title, abstract, and keyword screening. From these, 26 studies were finally included in this review. aMMP-8 point-of-care tests appear to be promising tools for early diagnosis, disease severity assessment, and treatment monitoring in periodontitis, though findings remain conflicting across studies. Elevated aMMP-8 levels are associated with active periodontal pathology and tissue destruction, reflecting ongoing collagenolytic degeneration. Conclusions: aMMP-8 mouthrinse, saliva, or oral fluid tests can be used for predictive and early diagnosis as well as for treatment monitoring in patients with periodontal disease, and they function effectively as biomarkers for periodontitis.
- 1 April 2021
- Vol. 55 (4) , 218-226
Functional Class II Treatment with a Miniplate-Anchored Herbst Appliance.
- 1 April 2021
- Vol. 55 (4) , 218-226
Functional Class II Treatment with a Miniplate-Anchored Herbst Appliance.
- 1 November 2012
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 76 (11) , 1547-1551
Effects of orthopedic maxillary expansion on nasal cavity size in growing subjects: A low dose computer tomography clinical trial
- 1 November 2012
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 76 (11) , 1547-1551
Effects of orthopedic maxillary expansion on nasal cavity size in growing subjects: A low dose computer tomography clinical trial